Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

QRxPharma meets with the FDA regarding MoxDuo NDA

Oct. 10, 2013

Gicare Pharma develops compounds for visceral pain

Oct. 10, 2013

Three clinical studies of Parkinson's disease candidate opicapone reported

Oct. 10, 2013

Alkermes completes enrollment in pivotal study of aripiprazole lauroxil

Oct. 10, 2013

NDC-1308, a novel compound inducing remyelination and slowing clinical signs in EAE mice

Oct. 10, 2013

Liver X receptor-beta agonists reported in Vitae Pharmaceuticals patent

Oct. 9, 2013

2B3-201 as a strategy for sustained and nontoxic release of methylprednisolone

Oct. 9, 2013

Novel metabotropic glutamate mGlu2 receptor PAMs disclosed by Bristol-Myers Squibb

Oct. 8, 2013

Vitae Pharmaceuticals presents new liver X receptor-beta agonists

Oct. 8, 2013

Novel myostatin inhibitors patented

Oct. 8, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...